Acorn Capital Advisors, Llc
Source: SEC Form 13F · as of Mar 2026Acorn Capital Advisors, Llc holds 11 biotech & pharma companies tracked by BioSniper, totaling $186.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$186.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Terns Pharmaceuticals, Inc. (TERN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| TERNTerns Pharmaceuticals, Inc. | 1,746,264 | $92.1M |
| PBYIPUMA BIOTECHNOLOGY, INC. | 4,131,299 | $26.4M |
| CADLCandel Therapeutics, Inc. | 3,497,948 | $17.2M |
| BCAXBicara Therapeutics Inc. | 643,382 | $12.8M |
| OKUROnKure Therapeutics, Inc. | 2,839,674 | $11.8M |
| JBIOJade Biosciences, Inc. | 786,760 | $11.1M |
| LONALeonaBio, Inc. | 634,539 | $6.5M |
| WHWKWhitehawk Therapeutics, Inc. | 1,139,363 | $3.9M |
| CRDFCardiff Oncology, Inc. | 1,762,084 | $2.9M |
| JSPRJasper Therapeutics Inc. | 1,411,492 | $1.2M |
| BCABBioAtla, Inc. | 5,406,345 | $865K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.